InvestorsObserver is giving Pacific Biosciences of California Inc (PACB) an Analyst Rating Rank of 30, meaning PACB is ranked higher by analysts than 30% of stocks. The average price target for PACB is $20.333 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating PACB a Buy today. Find out what this means to you and get the rest of the rankings on PACB!